Status:
RECRUITING
Long-Terms Responders in Metastatic Lung Cancer: Better Understanding for Better Management (Lungevity Study)
Lead Sponsor:
GFPC Investigation
Conditions:
Metastatic Lung Cancer
Metastatic NSCLC
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to identify and describe the clinical characteristics, health status, socio-economic impacts and quality of life of patients alive for three years after diagnos...
Eligibility Criteria
Inclusion
- Patient over 18 years old
- Patients alive after more than three years from diagnosis with stage IV or Stage III NSCLC or SCLC, not treated with cytotoxic chemotherapy at the time of inclusion (the patient may be undergoing imunotherapy, targeted therapy or surveillance).
- Patients covered by the French National Health Insurance program or with thirdparty-payer health insurance
Exclusion
- Difficulties for understanding French
- Patients undergoing treatment with cytotoxic chemotherapy
- Patients under legal guardianship, under curatorship or tutorship
- Insufficient cognitive capacity to answer questions
- Inability to obtain data collection (lost to follow-up, patient's refusal for data collection)
- Patients refusing the collection of their data (an information sheet will be provided)
Key Trial Info
Start Date :
July 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2031
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07243132
Start Date
July 2 2025
End Date
January 31 2031
Last Update
November 25 2025
Active Locations (46)
Enter a location and click search to find clinical trials sorted by distance.
1
CH du Pays d Aix
Aix-en-Provence, France, 13616
2
CHU Angers
Angers, France, 49033
3
Hôpital Henri Duffaut
Avignon, France, 84000
4
CH Bastia
Bastia, France, 20200